New ATC 5th levels 2025
| ATC code | ATC level name |
|---|---|
| A02BC10 | fexuprazan |
| A02BC11 | ilaprazole |
| A05AX07 | seladelpar |
| A10BD30 | gemigliptin and dapagliflozin |
| A10BK09 | enavogliflozin |
| A10XX02 | donislecel |
| A16AX24 | govorestat |
| A16AX25 | nedosiran |
| B02BD17 | fidanacogene elaparvovec |
| B02BX11 | marstacimab |
| B03XA09 | molidustat |
| B03XA10 | efepoetin alfa |
| B06AC07 | garadacimab |
| B06AC08 | sebetralstat |
| C01EB25 | acoramidis |
| C02KX06 | sotatercept |
| C08DA03 | etripamil |
| C09XX01 | sparsentan |
| C10BA13 | pitavastatin and ezetimibe |
| C10BX22 | rosuvastatin and nebivolol |
| J01DF51 | aztreonam and beta-lactamase inhibitor |
| J01RA17 | ofloxacin and nitazoxanide |
| J01RA18 | ofloxacin and tinidazole |
| J01RA19 | tetracycline and nystatin |
| J01XX13 | gepotidacin |
| J04AC02 | ftivazide |
| J04AM09 | pyrazinamide, ethambutol, isoniazid and lomefloxacin |
| J04AM10 | pyrazinamide, ethambutol, protionamide and lomefloxacin |
| J04AM11 | rifabutin, pyrazinamide and protionamide |
| J04AM12 | rifampicin, pyrazinamide, isoniazid and levofloxacin |
| J05AG07 | elsulfavirine |
| J05AP14 | narlaprevir |
| J05AR29 | emtricitabine, tenofovir alafenamide and dolutegravir |
| J05AX32 | riamilovir |
| J05AX33 | labuvirtide |
| J06BD09 | sipavibart |
| J07AH11 | meningococcus A,B,C,Y,W-135, pentavalent purified polysaccharides antigen conjugated and factor H binding protein |
| J07BB05 | influenza, RNA-based vaccine |
| L01DC05 | utidelone |
| L01EE05 | mirdametinib |
| L01EL06 | tirabrutinib |
| L01EX28 | repotrectinib |
| L01FD07 | zanidatamab |
| L01FX31 | zolbetuximab |
| L01FX32 | elranatamab |
| L01FX33 | tarlatamab |
| L01FX34 | odronextamab |
| L01FX35 | datopotamab deruxtecan |
| L01FX36 | patritumab deruxtecan |
| L01XH06 | tucidinostat |
| L01XH07 | resminostat |
| L01XL12 | obecabtagene autoleucel |
| L01XM03 | olutasidenib |
| L01XM04 | vorasidenib |
| L01XX81 | nirogacestat |
| L01XX82 | darinaparsin |
| L01XX83 | para-toluenesulfonamide |
| L01XX84 | pelabresib |
| L01XX85 | idroxioleic acid |
| L01XX86 | calaspargase pegol |
| L01XY04 | bifikafusp alfa and onfekafusp alfa |
| L03AX23 | motixafortide |
| L03AX24 | mavorixafor |
| L04AA60 | remibrutinib |
| L04AC26 | goflikicept |
| L04AG17 | seniprutug |
| L04AJ10 | vilobelimab |
| L04AJ11 | pozelimab |
| L04AX10 | tegomil fumarate |
| M01AE19 | loxoprofen |
| M01AE20 | pelubiprofen |
| N02CD08 | zavegepant |
| N06AX31 | zuranolone |
| N07BB06 | ondelopran |
| N07XX24 | trofinetide |
| N07XX25 | omaveloxolone |
| P01AB08 | satranidazole |
| P01AB53 | tinidazole and diloxanide |
| R07AX33 | deutivacaftor, tezacaftor and vanzacaftor |
| S01AX25 | lotilaner |
| S01EA55 | brimonidine and ripasudil |
| S01EE52 | latanoprost and dorzolamide |
| S01XA32 | avacincaptad pegol |
| S01XA33 | diquafosol |
| V04CX12 | xenon |
| V09IX18 | flotufolastat (18F) |
| V10XA04 | iodine (131I) apamistamab |
Last updated: 2024-12-03